Research graph
References from Proton pump inhibitors and durvalumab in PACIFIC. Local targets link to admitted publications; unresolved targets remain external evidence.
Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial
10.1016/s1470-2045(26)00191-9 · 2026 · External reference
Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer
10.1200/jco.21.01308 · 2022 · External reference
Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer
10.1056/nejmoa1709937 · 2017 · External reference
Proton pump inhibitors alter the composition of the gut microbiota
10.1136/gutjnl-2015-310861 · 2016 · External reference
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome
10.1016/j.cell.2024.05.029 · 2024 · External reference
